StockData

AVAI Bio, Inc. (AVAI) stock

AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026Market cap $17.24MP/E –Yield –

AVAI Bio ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

AVAI Bio's ebitda for the twelve months ending Jun 30, 2026 was -$1.79M. For fiscal 2026 it was -$1.72M. The highest annual figure on record is $108.70K in fiscal 2020.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$1.72M–
FY2025Mar 31, 2025-$1.07M–
FY2024Mar 31, 2024-$2.05M–
FY2023Mar 31, 2023-$325.52K-399.5%
FY2020Mar 31, 2020$108.70K–
FY2019Mar 31, 2019-$73.42K–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$546.80K-210.7%
Q4 FY2026CQ1 2026Mar 31, 2026-$248.66K–
Q3 FY2026CQ4 2025Dec 31, 2025-$547.21K-216.0%
Q2 FY2026CQ3 2025Sep 30, 2025-$446.50K-169.5%
Q1 FY2026CQ2 2025Jun 30, 2025$494.11K–
Q4 FY2025CQ1 2025Mar 31, 2025-$2.73M–
Q3 FY2025CQ4 2024Dec 31, 2024$471.82K-53.9%
Q2 FY2025CQ3 2024Sep 30, 2024$642.56K+56.7%
Q1 FY2025CQ2 2024Jun 30, 2024-$509.33K-221.1%
Q4 FY2024CQ1 2024Mar 31, 2024-$3.91M-1005.7%
Q3 FY2024CQ4 2023Dec 31, 2023$1.02M–
Q2 FY2024CQ3 2023Sep 30, 2023$409.94K+549.3%
Q1 FY2024CQ2 2023Jun 30, 2023$420.62K+145.2%
Q3 FY2021CQ4 2020Dec 31, 2020$431.29K–
Q2 FY2021CQ3 2020Sep 30, 2020-$36.41K–
Q1 FY2021CQ2 2020Jun 30, 2020$63.14K–
Q4 FY2020CQ1 2020Mar 31, 2020$171.55K–
Q4 FY2019CQ1 2019Mar 31, 2019-$24.53K–

More AVAI Bio figures

See a number that looks wrong?